Clinical Trial Update: Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy [Phase 1]

View source ↗

Summary

Phase 1 study evaluating talazoparib in combination with chemotherapy in relapsed pediatric acute myeloid leukemia to assess safety and preliminary efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Talzenna (talazoparib)

Snippet

Sponsor: Norman J. Lacayo | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: RECRUITING